Israel-based Anlit has been granted GMP certification by the Australian Therapeutic Goods Administration, the governmental authority charged with regulating therapeutic goods in the country.
The certification was granted to Anlit’s Kidi Bites, a supplement format designed specifically for children that is designed to overcome children’s typical reluctance to taking nutritional supplements.
Shai Karlinski, vice-president for marketing at Anlit, said the company had approached this certification as a strategic move
“Anlit had to follow a fast learning curve, forging beyond the former food supplement paradigms and adopting new pharma concepts and processes,” said Karlinski, adding that the certification would pave the way to partnerships with global pharmaceutical companies that are seeking diversification of their product portfolio with food supplements.
“Thanks to this important certification, Sanofi Aventis, just launched two of our Kidi Bites supplements for children in Australia,” added Karlinski.